| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 4.68% | 46.71% | -66.76% | 6/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 14.08% | 92.61% | 13.55% | 11/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 12.4% | 43.19% | 75.14% | 10/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 7.08% | 23.13% | 121.94% | 11/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 3.19% | 64.43% | -56.36% | 19/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 7.31% | -29.17% | -15.59% | 48/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 8.66% | -30.33% | 50.61% | 26/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 5.75% | -42.56% | 196.39% | 27/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.94% | -73.42% | -81.2% | 48/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 10.32% | -9.39% | -16.98% | 28/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 12.43% | 15.09% | 24.18% | 11/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 10.01% | 39.03% | 37.12% | 9/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 7.3% | 158.87% | -35.91% | 4/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 11.39% | 4.4% | 5.46% | 61/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 10.8% | -21.51% | 50% | 51/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 7.2% | -21.4% | 155.32% | 51/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.82% | -57.59% | -74.15% | 57/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 10.91% | -72% | -20.71% | 76/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 13.76% | -65.91% | 50.22% | 43/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 9.16% | -68.19% | 37.74% | 46/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 6.65% | 7.26% | -82.93% | 23/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 38.96% | 330.5% | -3.47% | 23/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 40.36% | 355.02% | 40.14% | 12/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 28.8% | 431.37% | 364.52% | 16/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 6.2% | 113.06% | -31.49% | 12/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 9.05% | 193.83% | 2.03% | 81/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 8.87% | 25.46% | 63.65% | 36/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 5.42% | 74.28% | 86.25% | 40/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.91% | 41.95% | -5.52% | 19/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 3.08% | 352.94% | -56.44% | 87/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 7.07% | 28.78% | 127.33% | 34/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 3.11% | 27.98% | 51.71% | 40/139 | 3.2% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 2.05% | -2.38% | 201.47% | 29/139 | 2.61% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 0.68% | -72.24% | -87.61% | 92/139 | 13.76% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 5.49% | 477.89% | 125.93% | 35/139 | 9.4% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 2.43% | 252.17% | 15.71% | 48/139 | 5.88% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.1% | 311.76% | -14.29% | 23/139 | 2.65% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 2.45% | 214.49% | 157.89% | 71/139 | 16.11% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 0.95% | 190.48% | 37.68% | 38/139 | 8.66% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 0.69% | 158.97% | 35.29% | 49/139 | 6.24% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 0.51% | 127.27% | 123.83% | 30/139 | 2.17% | 健帆生物 | 7.75% | 行业排名> |

微信公众号
证券之星APP


